Treatment of common gynecologic-endocrinologic symptoms by allergy management procedures.
The technique of managing allergies by optimum-dose (provocative neutralization) testing and treatment using aqueous progesterone has been studied in 132 women having progesterone-related symptoms due to the menstrual cycle, pregnancy, or exogenous hormone administration. When extremely small doses of progesterone (0.0016 mg or below, up to maximum of 2.5 mg) were administered following determination of specific dose requirement by skin testing, startlingly rapid and effective clearing of symptoms was observed. With these individualized doses, symptoms cleared completely or almost completely within 30 minutes in the majority of patients. A single-blind technique was employed to rule out placebo effect. Some common problems found to respond well to the procedure were nausea and vomiting during pregnancy (100%), premenstrual syndrome (96%), and dysmenorrhea (84%).
D004412:Dysmenorrhea / Q000188:drug therapy; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology; D008599:Menstruation Disturbances / Q000188:drug therapy* / Q000276:immunology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000276:immunology; D011293:Premenstrual Syndrome / Q000188:drug therapy; D011374:Progesterone / Q000008:administration & dosage*; D012882:Skin Tests
D011374:Progesterone